Automated versus manual oxygen titration in COPD exacerbation: machine or hands, this is the question

Automated versus manual oxygen titration in COPD exacerbation: machine or hands, this is the question

Gulsah Karaoren,1 Senay Goksu Tomruk,1 Antonio M Esquinas2 1Department of Anesthesiology and Reanimation, Istanbul Umraniye Research Hospital, Istanbul, Turkey; 2Intensive Care Unit, Hospital Morales Meseguer, Murcia, Spain We have read the article titled “Automated oxygen titrat...

Full description

Bibliographic Details
Main Authors:	Karaoren G, Goksu Tomruk S, Esquinas AM
Format:	Article
Language:	English
Published:	Dove Medical Press 2017-04-01
Series:	International Journal of COPD
Subjects:	COPD hyperoxia hypoxia oxygen inhalation therapy comorbid conditions
Online Access:	https://www.dovepress.com/letter-httpswwwdovepresscomautomated-oxygen-titration-and-w-peer-reviewed-article-COPD

Similar Items

Automated oxygen titration and weaning with FreeO2 in patients with acute exacerbation of COPD: a pilot randomized trial
by: Lellouche F, et al.
Published: (2016-08-01)

Automated oxygen control with O2matic® during admission with exacerbation of COPD
by: Hansen EF, et al.
Published: (2018-12-01)

The Importance of Inhaler Adherence to Prevent COPD Exacerbations
by: Jose R. Jardim, et al.
Published: (2019-04-01)

Lower versus higher oxygenation targets in ICU patients with haematological malignancy — insights from the HOT-ICU trial
by: Thomas L. Klitgaard, et al.
Published: (2022-12-01)

Decline of COPD exacerbations in clinical trials over two decades – a systematic review and meta-regression
by: Stefan Andreas, et al.
Published: (2019-08-01)

A mRNA panel for differentiation between acute exacerbation or pneumonia in COPD patients
by: Wilhelm Bertrams, et al.
Published: (2024-03-01)

Impact of mild exacerbation on COPD symptoms in a Japanese cohort
by: Sato M, et al.
Published: (2016-06-01)

Exploring the impact of number and type of comorbidities on the risk of severe COPD exacerbations in Korean Population: a Nationwide Cohort Study
by: Youngmee Kim, et al.
Published: (2021-05-01)

The paramount parameter: arterial oxygen tension versus arterial oxygen saturation as target in trials on oxygenation in intensive care
by: Olav Lilleholt Schjørring, et al.
Published: (2018-11-01)

2017 Global Initiative for Chronic Obstructive Lung Disease reclassifies half of COPD subjects to lower risk group
by: Högman M, et al.
Published: (2018-01-01)

Inhaled corticosteroid use by exacerbations and eosinophils: a real-world COPD population
by: Vestbo J, et al.
Published: (2019-04-01)

Cardiovascular Events According to Inhaler Therapy and Comorbidities in Chronic Obstructive Pulmonary Disease
by: Kim EK, et al.
Published: (2024-01-01)

The Long-Term Burden of COPD Exacerbations During Maintenance Therapy and Lung Function Decline
by: Kerkhof M, et al.
Published: (2020-08-01)

Use of inhaled devices during a hospital exacerbation of COPD: a summary of an interdisciplinary audit held at ICS Maugeri Pavia, Italy (March-June 2019)
by: Michele Vitacca, et al.
Published: (2020-02-01)

Lack of Association between Inhaled Corticosteroid Use and the Risk of Future Exacerbation in Patients with GOLD Group A Chronic Obstructive Pulmonary Disease
by: Sun Hye Shin, et al.
Published: (2022-05-01)

COPD: misuse of inhaler devices in clinical practice
by: Duarte-de-Araújo A, et al.
Published: (2019-05-01)

Evaluation of Inhaler Technique In COPD And Asthma Patients
by: Mohammed Hussein Abdulredha, et al.
Published: (2023-06-01)

Choosing the right inhaler for your asthma or COPD patient
by: Usmani OS
Published: (2019-03-01)

Contribution of Adenosine in the Physiological Changes and Injuries Secondary to Exposure to Extreme Oxygen Pressure in Healthy Subjects
by: Alain Boussuges, et al.
Published: (2022-08-01)

Overuse of inhaled corticosteroids in COPD: five questions for withdrawal in daily practice
by: Cataldo D, et al.
Published: (2018-07-01)

Impact of adherence to GOLD guidelines on symptom prevalence, lung function decline and exacerbation rate in a Swiss COPD cohort
by: Anja Jochmann, et al.
Published: (2012-03-01)

Pharmacological Treatment in Asthma and COPD
by: Tomoaki Hoshino, et al.
Published: (2009-01-01)

One-year mortality after severe COPD exacerbation in Bulgaria
by: Evgeni Mekov, et al.
Published: (2016-12-01)

Biomarkers for Comorbidities Modulate the Activity of T-Cells in COPD
by: Kaschin Jamal Jameel, et al.
Published: (2021-07-01)

Blood eosinophils and inhaled corticosteroids in patients with COPD: systematic review and meta-analysis
by: Cheng SL
Published: (2018-09-01)

Clinical heterogeneity of a population of patients admitted to the Emergency Department with a diagnosis of COPD-exacerbation: Relevance of cardiovascular comorbidities
by: Paolo Groff, et al.
Published: (2021-03-01)

Cardiovascular Diseases in COPD: From Diagnosis and Prevalence to Therapy
by: Anastasia Papaporfyriou, et al.
Published: (2023-05-01)

Inhaled Corticosteroids and the Lung Microbiome in COPD
by: Holly R. Keir, et al.
Published: (2021-09-01)

Oxygen: Friend or foe in the COVID‐19 battle
by: Kishan Chudasama, et al.
Published: (2021-12-01)

Effectiveness using higher inhaled corticosteroid dosage in patients with COPD by different blood eosinophilic counts
by: Cheng SL, et al.
Published: (2016-09-01)

Adherence to Inhaled Therapy in Patients with COPD Associated to Pneumoconiosis
by: Peng Y, et al.
Published: (2021-09-01)

In vivo T cell activation in lymphoid tissues is inhibited in the oxygen-poor microenvironment
by: Akio eOhta, et al.
Published: (2011-07-01)

Associated Factors of Pneumonia in Individuals with Chronic Obstructive Pulmonary Disease (COPD) Apart from the Use of Inhaled Corticosteroids
by: Rosario Lineros, et al.
Published: (2023-04-01)

Prediction of first acute exacerbation using COPD subtypes identified by cluster analysis
by: Yoon HY, et al.
Published: (2019-06-01)

Intraclass Difference in Pneumonia Risk with Fluticasone and Budesonide in COPD: A Systematic Review of Evidence from Direct-Comparison Studies
by: Lodise TP, et al.
Published: (2020-11-01)

Oxygen delivery is not a limiting factor during post-exercise recovery in healthy young adults
by: Robert T. Mankowski, et al.
Published: (2017-06-01)

Comorbidities associated with COPD in the Middle East and North Africa region: association with severity and exacerbations
by: Mahboub B, et al.
Published: (2016-02-01)

The comparative effectiveness of initiating fluticasone/salmeterol combination therapy via pMDI versus DPI in reducing exacerbations and treatment escalation in COPD: a UK database study
by: Jones R, et al.
Published: (2017-08-01)

Uric acid, lung function, physical capacity and exacerbation frequency in patients with COPD: a multi-dimensional approach
by: Kathrin Kahnert, et al.
Published: (2018-06-01)

Hypercapnic Failure in Acute Exacerbated COPD Patients: Severe Airflow Limitation as an Early Warning Signal
by: Achim Grünewaldt, et al.
Published: (2022-12-01)